Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Clark

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 2024
Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective StudyLakshmi Harinath, Tatiana M Villatoro, Beth Z Clark, et al.
American Journal of Clinical Pathology|June 23, 2023
Utility of TRPS1 immunohistochemistry in confirming breast carcinoma: Emphasis on staining in triple-negative breast cancers and gynecologic tumorsRayan Rammal, Kanika Goel, Esther Elishaev, et al.
American Journal of Clinical Pathology|February 26, 2026
Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancerJacob A Jerome, Rachel Vanderschelden, Beth Z Clark, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 15, 2020
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional studyRohit Bhargava, Nicole N Esposito, Siobhan M OʹConnor, et al.
American Journal of Clinical Pathology|May 10, 2018
Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?Alessandra Landmann, Daniel J Farrugia, Li Zhu, et al.
JAMA Surgery|December 6, 2023
Analyzing Surgical Technique in Diverse Open Surgical Videos With Multitask Machine LearningEmmett D Goodman, Krishna K Patel, Yilun Zhang, et al.
American Journal of Clinical Pathology|September 6, 2024
A comprehensive analysis of SOX17 expression by immunohistochemistry in human epithelial tumors, with an emphasis on gynecologic tumorsBeth Z Clark, T Rinda Soong, Kanika Goel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 8, 2023
Implementation of Digital Image Analysis in Assessment of Ki67 Index in Breast CancerRachel K Vanderschelden, Jacob A Jerome, Daniel Gonzalez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumorsDaniel J Farrugia, Alessandra Landmann, Li Zhu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapyMin Han, Arsalan Salamat, Li Zhu, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 2024
Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective StudyLakshmi Harinath, Tatiana M Villatoro, Beth Z Clark, et al.
American Journal of Clinical Pathology|June 23, 2023
Utility of TRPS1 immunohistochemistry in confirming breast carcinoma: Emphasis on staining in triple-negative breast cancers and gynecologic tumorsRayan Rammal, Kanika Goel, Esther Elishaev, et al.
American Journal of Clinical Pathology|February 26, 2026
Magee Equation 3 demonstrates predictive and prognostic value for neoadjuvant chemotherapy outcomes in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancerJacob A Jerome, Rachel Vanderschelden, Beth Z Clark, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 15, 2020
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional studyRohit Bhargava, Nicole N Esposito, Siobhan M OʹConnor, et al.
American Journal of Clinical Pathology|May 10, 2018
Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?Alessandra Landmann, Daniel J Farrugia, Li Zhu, et al.
JAMA Surgery|December 6, 2023
Analyzing Surgical Technique in Diverse Open Surgical Videos With Multitask Machine LearningEmmett D Goodman, Krishna K Patel, Yilun Zhang, et al.
American Journal of Clinical Pathology|September 6, 2024
A comprehensive analysis of SOX17 expression by immunohistochemistry in human epithelial tumors, with an emphasis on gynecologic tumorsBeth Z Clark, T Rinda Soong, Kanika Goel, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 8, 2023
Implementation of Digital Image Analysis in Assessment of Ki67 Index in Breast CancerRachel K Vanderschelden, Jacob A Jerome, Daniel Gonzalez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumorsDaniel J Farrugia, Alessandra Landmann, Li Zhu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapyMin Han, Arsalan Salamat, Li Zhu, et al.
Pageof 6